Prophylactic Racemic Epinephrine in Anterior Cervical Discectomy and Fusion

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Dysphagia, Dysphonia, Postoperative Pain

In brief

Our double-blinded, randomized control trial will assess the effect of nebulized racemic epinephrine inpatients undergoing anterior cervical discectomy and fusion (ACDF) procedures. The investigators have had success in managing post-operative dysphagia in patients undergoing ACDF with the administration of this drug. Half of the participants will review nebulized epinephrine. The other half will receive placebo.

Key facts

Study ID

NCT02724761

Run by

Andrew Chung

People needed

90

Starts

2016-09-01

Expected to finish

2018-09-01

Last updated by the study team

2016-03-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients > 18 years of age
• Primary two and three-level ACDF between C3-7
• Approved pre-authorization to undergo the procedure

You may not qualify if…

• Patients < 18 years of age
• Patients who are unable to give their own consent
• Revision ACDF
• Combined anterior-posterior surgeries
• Surgeries involving C2-C3 or C7-T1
• Surgeries related to trauma, infection, or tumor
• Patients with baseline swallowing dysfunction
• Patients currently on steroids
• Patients with severe cardiac disease
• Uncontrolled diabetics as defined by patients with a HbA1C > 8%
• Patients with known allergy to epinephrine

Where it is running

• Banner University Medical Center — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.